Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.21
Delayed Data
As of Aug 27
 +0.74 / +1.83%
Today’s Change
39.27
Today|||52-Week Range
49.24
-3.58%
Year-to-Date

Today’s Trading

Previous close40.47
Today’s open40.76
Day’s range40.68 - 41.33
Volume3,955,035
Average volume (3 months)4,094,500
Market cap$98.5B
Dividend yield6.04%
Data as of 4:03pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)-46.46%
Earnings growth (this year)-20.75%
Earnings growth (next 5 years)+5.10%
Revenue growth (last year)-8.75%
P/E ratio10.4
Price/Sales2.74
Price/Book14.81

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.79+1.32%
CELGCelgene+3.81+3.20%
ABBVAbbVie+1.37+2.17%
LLYEli Lilly and Co+2.64+3.26%
Data as of 4:06pm ET, 08/27/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)$0.63
Annual revenue (last year)$37.9B
Annual profit (last year)$4.5B
Net profit margin11.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers